Announced Sat, 27 Jun · 11:58 IST
Trading window closed pending June 2026 quarter results declaration
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-7.8%1-day move
₹19.00
prior close
₹18.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-7.8-3.2-1.6-5.2+0.8-2.8-8.9———
Up moveDown movePending
AI summary
Venmax Drugs and Pharmaceuticals has closed its trading window ahead of declaring unaudited financial results for the quarter ended June 30, 2026. This is a routine SEBI compliance measure under insider trading regulations. Insiders including directors, KMPs, and designated employees cannot trade in company shares until results are announced and the window reopens, typically 48 hours after results publication.
Likely market impact
Insiders cannot trade shares until results are declared and window reopens. Routine compliance, no direct impact on retail shareholders.